Embryonic stem cells have the extraordinary ability to divide without limit yet maintain the potential to make all types of cells found in the human body. This holds tremendous implications for the worlds of drug discovery and testing, cell production, and tissue transplantation medicine.
Overall, I’m really glad I decided to go to the talk. I got to learn a lot about stem cells, how they are used in different parts of the body, and some of the difficulties with using stem cells. It was definitely way more enjoyable than anything else I was planning on doing during that time. If there are more opportunities like this that come up, I would definitely try to go to them.
Celebrating the 20th anniversary of Dr. James
Thomson’s breakthrough work with induced pluripotent stem cells, the Wisconsin
Institute for Discovery (WID) hosted a panel of University of Wisconsin stem
cell scientists to discuss the future of their research on November 13th. Entitled “Stem Cell Science: The Next 20
Years” and designed for the general public, the audience heard from Drs. Lynn Allen
Hoffman, David Gamm and
Vereide, who talked about applying stem cell
research to develop clinical applications for skin grafting, vision restoration
and regenerative biology, respectively.
20 Years of Human Pluripotent Stem Cells: Current Clinical Trials and Regulatory Framework
April 18, 2018 | Madison, WI
Over the years, the BTC Institute has partnered with the Stem Cell & Regenerative Medicine Center, at the University of Wisconsin-Madison to offer this packed day of excellent talks and opportunities to interact with renowned speakers, poster session presenters, sponsor representatives and other attendees.
Our UW-Madison committee members define each year’s content and pull together a strong group of presenters. This year, we’re working with Timothy J. Kamp, M.D. (Professor, Medicine, Cell and Regenerative Biology; Co-director, Stem Cell and Regenerative Medicine Center), William L. Murphy, Ph.D. (Professor, Biomedical Engineering, Orthopedics & Rehabilitation; Co-director, Stem Cell & Regenerative Medicine Center) and James Thomson, Ph.D. (John D. MacArthur Professor, Director, Regenerative Biology, Morgridge Institute for Research; Professor, Department of Molecular, Cellular, & Developmental Biology, University of California – Santa Barbara).
Our 2018 symposium brings together leading researchers advancing human pluripotent stem cell products to clinical applications for a range of degenerative diseases. Progress in clinical trials, as well as major barriers for developing these revolutionary new therapies will be discussed.
As Dr. Kamp notes, “This will be a remarkable meeting highlighting the emerging field of regenerative medicine which has grown from the pioneering discovery of human embryonic stem cells 20 years ago.” Continue reading